Melatonin at the Crossroads of Oxidative Stress, Immunity, and Cancer Therapy
Antioxidants · 03.01.2026 · 15 (1) · 64
DOI: 10.3390/antiox15010064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 03.01.2026. Verfasst von Elena Lavado-Fernández und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Biology and Genomics (IBFG), University of Salamanca/CSIC, 37007 Salamanca, Spain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, FPI contract, Plan Especial Grado Medicina.
Abstract (Originalsprache)
Melatonin, an ancient and evolutionarily conserved indolamine, has long attracted attention for its multifunctional roles in redox homeostasis. More recently, it has been studied in relation to immune regulation and cancer biology. Beyond its well-known circadian function, melatonin modulates oxidative stress by directly scavenging reactive oxygen and nitrogen species and by upregulating antioxidant enzymes, including superoxide dismutase, catalase, and glutathione peroxidase. At the same time, it exerts wide-ranging immunomodulatory functions by influencing both innate and adaptive immune responses. All these actions converge within the tumor microenvironment, where oxidative stress and immune suppression drive cancer progression. Although the antitumoral effects of melatonin have traditionally been interpreted through its actions on T cells and NK cells, recent studies identify macrophages as an underappreciated and pivotal target. Notably, melatonin influences macrophage polarization, favoring antitumor M1 phenotypes over pro-tumoral M2 states, while attenuating chronic inflammation and restoring mitochondrial function. This review summarizes current knowledge on melatonin’s antioxidant and immunoregulatory mechanisms, highlighting its impact on the tumor immune microenvironment, with a particular focus on the growing recognition of macrophages as a compelling new axis through which melatonin may exert anticancer effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Functional Biology and Genomics (IBFG), University of Salamanca/CSIC, 37007 Salamanca, Spain.
- Department of Biochemistry and Molecular Biology, Universidad de Salamanca, 37007 Salamanca, Spain.
- Institute of Neuroscience of Castilla y Leon (INCyL), 37007 Salamanca, Spain.
- Department of Human Anatomy and Histology, Universidad de Salamanca, 37008 Salamanca, Spain.
- Department of Statistics, Universidad de Salamanca, 37007 Salamanca, Spain.
ORCID-Profile: Elena Lavado-Fernández, Cristina Pérez-Montes, Miguel Robles-García, Adrián Santos-Ledo, Marina García-Macia
Förderung
- Agencia Estatal de Investigación
- FPI contract
- Plan Especial Grado Medicina
- Lanzadera TCUE and C2 program
- European Union NextGenerationEU/PRTR
- FEDER, UE
Zitieren
APA
Lavado-Fernández, E., Pérez-Montes, C., Robles-García, M., Santos-Ledo, A., & García-Macia, M. (2026). Melatonin at the Crossroads of Oxidative Stress, Immunity, and Cancer Therapy. Antioxidants, 15(1), 64. https://doi.org/10.3390/antiox15010064
Vancouver
Lavado-Fernández E, Pérez-Montes C, Robles-García M, Santos-Ledo A, García-Macia M. Melatonin at the Crossroads of Oxidative Stress, Immunity, and Cancer Therapy. Antioxidants. 2026;15(1):64. doi:10.3390/antiox15010064
BibTeX
@article{LavadoFernndez2026,
author = {Lavado-Fernández, Elena and Pérez-Montes, Cristina and Robles-García, Miguel and Santos-Ledo, Adrián and García-Macia, Marina},
title = {Melatonin at the Crossroads of Oxidative Stress, Immunity, and Cancer Therapy},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {1},
pages = {64},
doi = {10.3390/antiox15010064}
}
EUVIMED